What peptides are, why they are studied, and how OpenLab approaches evidence

Peptides are short chains of amino acids. They sit between single amino acids and larger proteins. The body already uses peptides as messengers — signals that help cells coordinate repair, metabolism, inflammation, and other processes.
Because they are relatively small and specific, many peptides can interact with particular pathways. That is why they have become an active research area in regenerative biology, performance, and aging science.
Longevity research is not only about adding years. It is also about how well tissues recover, how mitochondrial function holds up, and how repair stays in balance. Some peptides are studied because they appear to influence these systems in targeted ways.
OpenLab treats peptides as a research category that needs better documentation — not as a finished product category. The questions we hold are simple:
The current OpenLab review set includes compounds with growing scientific literature, including BPC-157, TB-500, MOTS-c, SS-31, and GHK-Cu. These are discussed as research materials. They are not presented as treatments.
In this field, the gap is often not a lack of interest. It is a lack of consistent standards. Identity, purity, documentation, and interpretation vary widely. OpenLab’s role is to help organize that information and keep a clear line between peer-reviewed evidence and frontier claims.
This article is educational. It is not medical advice. It does not recommend personal use.

Lorem ipsum dolor sit amet consectetur consequat aliquam sit eget sed tortor tempor eget varius massa.